Get started
Author

Ruggero Dittadi

Observed names: Dittadi R., Dittadi, R., Dittadi, Ruggero, R DITTADI, R Dittadi, R. DITTADI, R. Dittadi, Ruggero DITTADI
Observed institutions: University of Padua, Mario Negri Institute for Pharmacological Research, University of Washington, Tokyo Metropolitan Komagome Hospital, Regional Medical Center, Ospedale dell' Angelo, Piedmont Reference Center for Epidemiology and Cancer Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Ospedale Civile di Venezia, Regione Piemonte
ORCID: 0000-0003-2274-9648
Observed ORCID: 0000-0003-2274-9648
OpenAlex ID: A5082754231
Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
1997 · G. Gasparini, E. Bonoldi, et al. · JNCI Journal of the National Cancer Institute · 498
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.
1997 · M L Disis, S M Pupa, et al. · Journal of Clinical Oncology · 348
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
1999 · G Gasparini, M Toi, et al. · PubMed · 117
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
1999 · M Gion, R Mione, et al. · PubMed · 87
Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate
2004 · Elga Pezzato, Luigi Sartor, et al. · International Journal of Cancer · 77
Validation of Blood Collection Procedures for the Determination of Circulating Vascular Endothelial Growth Factor (VEGF) in Different Blood Compartments
2001 · R. Dittadi, S. Meo, et al. · The International Journal of Biological Markers · 75
PDF
Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game
2002 · M. Gion, P. Boracchi, et al. · European Journal of Cancer · 68
Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: A multi-center study
2019 · Aldo Clerico, Andrea Ripoli, et al. · Clinica Chimica Acta · 62
A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study)
2018 · Aldo Clerico, Tommaso Trenti, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 49
Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance
2023 · Aldo Clerico, Martina Zaninotto, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 41
PDF
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer
1989 · Emilio Bombardieri, Massimo Gion, et al. · Cancer · 39
PDF
Evaluation of 99th percentile and reference change values of a high-sensitivity cTnI method: A multicenter study
2019 · Aldo Clerico, Andrea Ripoli, et al. · Clinica Chimica Acta · 37
PDF
Thrombospondin-1 and -2 in Node-Negative Breast Cancer: Correlation with Angiogenic Factors, p53, Cathepsin D, Hormone Receptors and Prognosis
2000 · Giampietro Gasparini, Masakazu Toi, et al. · Oncology · 37
Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue
1993 · R Dittadi, PM Donisi, et al. · British Journal of Cancer · 37
PDF
ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.
1997 · R Dittadi, A Brazzale, et al. · PubMed · 35
Comparison between Two Methods in the Determination of Circulating Chromogranin A in Neuroendocrine Tumors (NETs): Results of a Prospective Multicenter Observational Study
2005 · A. Leon, M. Torta, et al. · The International Journal of Biological Markers · 33
Evaluation of HER-2/neu in Serum and Tissue of Primary and Metastatic Breast Cancer Patients using an Automated Enzyme Immunoassay
2001 · R. Dittadi, M. Zancan, et al. · The International Journal of Biological Markers · 33
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer
1995 · M. Gion, R. Mione, et al. · European Journal of Cancer · 33
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck
2003 · E Ferruzzi, R Franceschini, et al. · European Journal of Cancer · 31
Quality Control for Biomarker Determination in Oncology: The Experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)
2002 · A. Paradiso, S. Volpe, et al. · The International Journal of Biological Markers · 31
PDF
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma
1986 · Massimo Gion, Riccardo Mione, et al. · Cancer · 31
PDF
Harmonization protocols for TSH immunoassays: a multicenter study in Italy
2017 · Aldo Clerico, Andrea Ripoli, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 28
Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls
2004 · Girolamo Ranieri, Maria Coviello, et al. · Oncology Reports · 28
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications
1997 · Masakazu Toi, Massimo Gion, et al. · Angiogenesis · 28
A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods
2017 · Aldo Clerico, Lucia Belloni, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 26
Works count: 127
Citation count: 2,611
H-index: 25
I10-index: 54
Year
Topic
Type